BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16540020)

  • 1. [Prevention and rehabilitation in cardiology].
    del Río Ligorit A
    Rev Esp Cardiol; 2006; 59 Suppl 1():50-4. PubMed ID: 16540020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes.
    Lavie CJ; Milani RV
    J Cardiopulm Rehabil; 2005; 25(2):59-66. PubMed ID: 15818190
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.
    Heinl RE; Dhindsa DS; Mahlof EN; Schultz WM; Ricketts JC; Varghese T; Esmaeeli A; Allard-Ratick MP; Millard AJ; Kelli HM; Sandesara PB; Eapen DJ; Sperling L
    Can J Cardiol; 2016 Oct; 32(10 Suppl 2):S349-S357. PubMed ID: 27692115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategies for cardiovascular prevention in the elderly].
    Fattirolli F; Orso F
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):97S-101S. PubMed ID: 20879492
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of cardiovascular risk factors: moving upstream.
    Smith ER
    Can J Cardiol; 2010; 26 Suppl C(Suppl C):7C. PubMed ID: 20847984
    [No Abstract]   [Full Text] [Related]  

  • 6. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019.
    Précoma DB; Oliveira GMM; Simão AF; Dutra OP; Coelho OR; Izar MCO; Póvoa RMDS; Giuliano ICB; Alencar Filho AC; Machado CA; Scherr C; Fonseca FAH; Santos Filho RDD; Carvalho T; Avezum Á; Esporcatte R; Nascimento BR; Brasil DP; Soares GP; Villela PB; Ferreira RM; Martins WA; Sposito AC; Halpern B; Saraiva JFK; Carvalho LSF; Tambascia MA; Coelho-Filho OR; Bertolami A; Correa Filho H; Xavier HT; Faria-Neto JR; Bertolami MC; Giraldez VZR; Brandão AA; Feitosa ADM; Amodeo C; Souza DDSM; Barbosa ECD; Malachias MVB; Souza WKSB; Costa FAAD; Rivera IR; Pellanda LC; Silva MAMD; Achutti AC; Langowiski AR; Lantieri CJB; Scholz JR; Ismael SMC; Ayoub JCA; Scala LCN; Neves MF; Jardim PCBV; Fuchs SCPC; Jardim TSV; Moriguchi EH; Schneider JC; Assad MHV; Kaiser SE; Lottenberg AM; Magnoni CD; Miname MH; Lara RS; Herdy AH; Araújo CGS; Milani M; Silva MMFD; Stein R; Lucchese FA; Nobre F; Griz HB; Magalhães LBNC; Borba MHE; Pontes MRN; Mourilhe-Rocha R
    Arq Bras Cardiol; 2019 Nov; 113(4):787-891. PubMed ID: 31691761
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
    Verhaegen AA; Van Gaal LF
    J Endocrinol Invest; 2017 Nov; 40(11):1165-1174. PubMed ID: 28660606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?
    Osei K
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4220-2. PubMed ID: 20823471
    [No Abstract]   [Full Text] [Related]  

  • 9. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 10. Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.
    Cosentino F; Ceriello A; Baeres FMM; Fioretto P; Garber A; Stough WG; George JT; Grant PJ; Khunti K; Langkilde AM; Plutzky J; Rydén L; Scheen A; Standl E; Tuomilehto J; Zannad F
    Eur Heart J; 2019 Sep; 40(34):2907-2919. PubMed ID: 30445605
    [No Abstract]   [Full Text] [Related]  

  • 11. The 10-year anniversary of the European Association for Cardiovascular Prevention and Rehabilitation: achievements and challenges.
    Perk J; DeBacker G; Saner H; Wood D; Giannuzzi P; Gielen S; Pelloiccia A
    Eur J Prev Cardiol; 2015 Oct; 22(10):1340-5. PubMed ID: 25208907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation].
    Velasco JA; Cosín J; Maroto JM; Muñiz J; Casasnovas JA; Plaza I; Abadal LT
    Rev Esp Cardiol; 2000 Aug; 53(8):1095-120. PubMed ID: 10956605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complex cardiac rehabilitation in a strategy of secondary prevention of cardiovascular disease].
    Kałka D; Sobieszczańska M; Pilecki W; Adamus J
    Pol Merkur Lekarski; 2009 Jul; 27(157):30-5. PubMed ID: 19650426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
    Perk J; De Backer G; Gohlke H; Graham I; Reiner Z; Verschuren WM; Albus C; Benlian P; Boysen G; Cifkova R; Deaton C; Ebrahim S; Fisher M; Germano G; Hobbs R; Hoes A; Karadeniz S; Mezzani A; Prescott E; Ryden L; Scherer M; Syvänne M; Scholte Op Reimer WJ; Vrints C; Wood D; Zamorano JL; Zannad F; ;
    Atherosclerosis; 2012 Jul; 223(1):1-68. PubMed ID: 22698795
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.
    Piepoli MF; Corrà U; Adamopoulos S; Benzer W; Bjarnason-Wehrens B; Cupples M; Dendale P; Doherty P; Gaita D; Höfer S; McGee H; Mendes M; Niebauer J; Pogosova N; Garcia-Porrero E; Rauch B; Schmid JP; Giannuzzi P
    Eur J Prev Cardiol; 2014 Jun; 21(6):664-81. PubMed ID: 22718797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shape of the Nations survey and attitudes to cardiometabolic risk.
    Wierzbicki AS; Ganotakis ES; Mikhailidis DP
    Curr Med Res Opin; 2007 Jan; 23(1):25-8. PubMed ID: 17261235
    [No Abstract]   [Full Text] [Related]  

  • 17. [The best of epidemiology and cardiovascular prevention in 2005].
    Thomas D; Cambou JP; Zeller M; Danchin N; Empana JP; Ferrières J; Jouven X; Paillard F; Valensi P; Cottin Y; ;
    Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):49-56. PubMed ID: 16479964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mediterranean-style diet and metabolic syndrome.
    Meydani M
    Nutr Rev; 2005 Sep; 63(9):312-4. PubMed ID: 16220642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders.
    Pradhan A
    Nutr Rev; 2007 Dec; 65(12 Pt 2):S152-6. PubMed ID: 18240540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.